Table 1 Structures, select interacting partners, and cellular functions of human caspases and their disease associations.
Caspase | PDB entrya | Select interacting partnerb | Cellular function | Diseasec | Disease-associating mutationd | Inhibitor | Reference |
---|---|---|---|---|---|---|---|
CASP1 | 1IBC,1ICE,1RWK,1RWM,1RWN,1RWO,1RWP,1RWV,1RWW,1RWX,1SC1,1SC3,1SC4,2FQQ,2H48,2H4W,2H4Y,2H51,2H54,2HBQ,2HBR,2HBY,2HBZ,5MMV,5MTK,6PZP,1BMQ,3D6F,3D6H,3D6M,3NS7,6BZ9,6F6R,3E4C,5FNA,8WRA,6VIE,6KN0,8SV1,7KEU | ARID4B,BRCA1,CARD16,FMN2,GAB1,GSDMD,IFI16,IL1B,KIF11,KIF3A,NLRC4,PI4KB,PLCL2,PYCARD,RNF31,VAC14 | Pyroptosis,PANoptosis,Metabolism | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric), Osteoporosis, Parkinson (late onset), Ataxia-telangiectasia, Multiple sclerosis, Rheumatoid arthritis, Retinitis pigmentosa, Lynch syndrome, Pulmonary hypertension, Cone-Rod dystrophy, Sickle cell, Cardio- and nephrological diseases, Schizophrenia, Familial Mediterranean fever, Asthma, Chronic lymphocytic leukemia | K37Q, V61I, C72F | Minocycline, Pralnacasan, LAX-101, Emricasan, VX-765, Z-VAD, VX-166, Belnacasan | |
CASP2 | 3R5J,3R6G,3R6L,3R7B,3R7N,3R7S,1PYO,2P2C,3RJM,6GKF,6GKG,6S9K,6SAD,6Y8B,6Y8D | BBOX1,BID,BIRC2,CASP3,CASP8,CIB1,CRADD,EPN3,HNRNPK,PIDD1,RFXANK,TRAF1,TRAF2,TRAF3 | Cell cycle,Autophagy,Genome stability,Tumorigenesis,Tumor suppression,Aging,Apoptosis | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Head and neck, Brain), Familial Alzheimer disease, Osteoporosis, Ataxia-telangiectasia, Ischemic stroke, Multiple sclerosis, Lynch syndrome, Neurofibromatosis type I, Lung cancer susceptibility, Myeloma, Multiple leukemia, Chronic lymphocytic squamous cell carcinoma | R234Glb, R265lb | Emricasan, Z-VAD, VX-166 | |
CASP3 | 1GFW,1NME,1PAU,1RE1,1RHJ,1RHK,1RHM,1RHQ,1RHR,1RHU,2C1E,2C2K,2C2M,2C2O,2CDR,2CJX,2CJY,2CNK,2CNL,2CNN,2CNO,2DKO,2H5I,2H5J,2H65,2XYG,2XYH,2XYP,2XZD,2XZT,2Y0B,3EDQ,3GJQ,3GJR,3GJS,3GJT,3KJF,4DCJ,4DCO,4DCP,5IC4,6BDV,6BFJ,6BFK,6BFL,6BFO,6BG0,6BG1,6BG4,6BGK,6BGQ,6BGR,6BGS,6BH9,6BHA,6CKZ,6CL0,6X8I,6X8K,7RN7,7RN8,7RN9,7RNA,7RNB,7RNC,7RND,7RNE,7RNF,7RNG,7SEO,7USO,7USP,7USQ,1CP3,1NMQ,1NMS,1QX3,2J30,2J31,2J32,2J33,3H0E,3ITN,3PCX,3PD0,3PD1,4EHA,4EHD,4EHF,4EHH,4EHK,4EHL,4EHN,4JJE,4JQY,4JQZ,4JR0,4PRY,4PS0,4QTX,4QTY,4QU0,4QU5,4QU9,4QUA,4QUB,4QUD,4QUJ,4QUL,5I9B,5IAJ,5IAK,5IAS,5IBC,5IBP,3DEH,3DEI,3DEJ,3DEK,4QU8,4QUE,4QUG,4QUH,4QUI,5I9T,5IAB,5IAE,5IAG,5IAN,5IAR,5IBR,1I3O,7XN4,7XN5,7XN6 | XIAP,PARP1,BIRC2,CASP9,CDKN1A,CRYAB,MDM2,BIRC5,BIRC6,CASP6,CASP8,CFLAR,HCLS1,MAPT,AFP,ARNT,BID,BIRC3,BIRC7,CASP2,CTTN | Apoptosis, PANoptosis, Pyroptosis, Autophagy, Stem cell and neural differentiation | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Esophageal, Endometrial, Brain), Type 1 and 2 diabetes mellitus, Systemic lupus erythematosus, Familial Alzheimer disease, Amyotrophic lateral sclerosis, Hypertension, Acute myeloid leukemia, Crohn’s disease, Age-related macular degeneration, Osteoporosis, Parkinson disease (late onset), Ataxia-telangiectasia, Complementation group Fanconi anemia, Ischemic stroke, Rheumatoid arthritis, Familial meningioma, Duchenne muscular dystrophy, Multiple sclerosis, Retinitis pigmentosa, Nonpapillary renal cell carcinoma, Malaria, Cystic fibrosis, Gastrointestinal stromal tumor, Neural tube defects, Cone-Rod dystrophy, Leptin deficiency, Interstitial lung disease, Medulloblastoma and retinoblastoma, Dilated cardiomyopathy, Schizophrenia, Nephrological diseases, Head and neck squamous cell carcinoma, Lung cancer susceptibility, Autism spectrum disorder, Chronic lymphocytic leukemia, Multiple myeloma, Ulcerative colitis, Tuberous sclerosis, Asthma, Tatton-Brown-Rahman syndrome, Familial adenomatous polyposis | E25Klb, E34Klb, R75Hlb, R101Hlb, R110Hlb | Glycyrrhizic acid, Minocycline, Oleandrin, Pamidronic acid, Emricasan, Z-VAD, VX-166, Calpain | |
CASP4 | 6NRY,7WR0,7WR6,7WR1,6KMZ,8SPB,8J6K,7WR4,7WR5 | CASP5 | Apoptosis, Pyroptosis, ER stress | Neuroblastoma, Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Esophageal, Brain), Familial Alzheimer disease, Hypertension, Age-related macular degeneration, Parkinson disease (late onset), Complementation group Fanconi anemia, Nonpapillary renal cell carcinoma, Gastrointestinal stromal tumor, Neural tube defects, Cone-Rod dystrophy, Schizophrenia, Lung cancer susceptibility, Multiple myeloma | E228D, E284D, D47N | Incadronic acid, Emricasan, Z-VAD, VX-166 | |
CASP5 | – | ARHGAP44, CASP4,LACRT | Pyroptosis | Cancer (Colorectal, Lung, Prostate, Breast, Pancreatic, Ovarian, Gastric, Brain, Endometrial), Nonpapillary renal cell carcinoma, Lynch syndrome, Retinoblastoma, Familial Mediterranean fever, Ulcerative colitis | R11Hlb, R24Hlb, E164Qlb, E240Qlb, E324Qlb, E382Qlb, E395Qlb | ||
CASP6 | 3P4U,3P45,3QNW,8EG5,8EG6,3NKF,3V6L,4IYR,2WDP,3K7E,3NR2,3OD5,3S70,4EJF,4FXO,4HVA,4N5D,4N6G,4N7J,4N7M,4NBK,4NBL,4NBN,6DEU,6DEV,8F78,8F96,8F98,8F99,8F9A,8F9B,8F9C,8F9D,8FBV,3S8E,3V6M,8F97 | CASP3,CASP8,MAPT,STUB1,USP15 | Apoptosis, PANoptosis, Synaptic loss and disfunction, B-cell proliferation | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Endometrial, Esophageal, Brain), Familial Alzheimer disease, Amyotrophic lateral sclerosis, Interstitial lung disease, Lung cancer susceptibility, Head and neck squamous cell carcinoma, Multiple myeloma, Chronic lymphocytic leukemia | - | Emricasan, Z-VAD, VX-166 | |
CASP7 | 2QLF,3IBC,3IBF,5IC6,6X8J,6X8L,2QL5,2QL7,2QL9,2QLB,2QLJ,3EDR,4JB8,4LSZ,4ZVO,4ZVP,4ZVQ,4ZVR,4ZVS,4ZVT,4ZVU,5K20,6CL1,6CL2,1K86,1K88,1SHJ,1SHL,4FDL,4FEA,4HQ0,4HQR,4JJ8,4JR1,4JR2,5V6U,5V6Z,8DGZ,8DJ3,1F1J,1GQF,3H1P,3R5K,1I51,1I4O,1KMC,7WZS | ATXN3,BIRC2,BIRC3,BIRC5, BIRC6,CASP8,CCT2,CRYAB, FBXW11,HNRNPH1,HSPA5,NFE2L2, PARP1,PTGES3, RB1,SAT1,TRIM25,XIAP | Apoptosis, PANoptosis, Bone development, Dentinogenesis | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Esophageal, Endometrial), Familial Alzheimer disease, Crohn’s disease, Age-related macular degeneration, Parkinson disease (late onset), Type 1 diabetes mellitus, Rheumatoid arthritis, Ischemic stroke, Duchenne muscular dystrophy, Nonpapillary renal cell carcinoma, Retinitis pigmentosa, Osteoarthritis, Chronic nephrological diseases, Chronic lymphocytic leukemia, Head and Neck squamous cell carcinoma, Tatton-Brown-Rahman syndrome, Lung cancer susceptibility | D230E, T244S, D255E, D263E, D288E, D340E | Fica, Emricasan, Incadronic acid, Z-VAD, VX-166 | |
CASP8 | 1F9E,1QDU,1QTN,2C2Z,3KJN,3KJQ,6X8H,2K7Z,4JJ7,4PRZ,4ZBW,5H31,5H33,6AGW,7LVJ,7LVM,2Y1L,4PS1,5L08,6PX9,1I4E,5JQE,2FUN,3H11,7DEE,8YM4,8YM5,8YM6,8YNK,8YNL,8YNM,8YNN,8YBX,8YD7,8YD8,8YNI | BCAP31,BCL2,BID,BIRC2,BIRC3,CASP2, CASP3,CASP6,CASP7,CASP9,CASP10,CFLAR,CUL3,DEDD,DEDD2,FADD,FAF1, FAS,FASLG,GMEB1,HECTD3,HIP1,IKBKB, IL1B,MAP1LC3B,NLRC4,NOL3,PEA15, PIK3C3,PML,PRDX6,PTEN,PYCARD, RIPK1,RIPK3,RNF34,SQSTM1,SRC, TICAM1,TNF,TNFAIP3,TNFRSF10A, TNFRSF10B,TNFSF10,TRADD, TRAF1,TRAF2,TRAF6,XIAP | Apoptosis, Pyroptosis, PANoptosis, Necroptosis, Lens cell differentiation, Terminal keratinocytes differentiation, Erythrocytes & platelet formation, T & B cell proliferation | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Gastric, Ovarian, Esophageal, Brain, Endometrial), Type 2 diabetes mellitus, Systemic lupus erythematosus, Amyotrophic lateral sclerosis, Familial Alzheimer disease, Acute myeloid leukemia, Crohn’s disease, Age-related macular degeneration, Osteoporosis, Parkinson disease (late onset), Ataxia-telangiectasia, Type 1 diabetes mellitus, Multiple sclerosis, Familial meningioma, Complementation group Fanconi anemia, Rheumatoid arthritis, Ischemic stroke, Nonpapillary renal cell carcinoma, Cystic fibrosis, Type I neurofibromatosis, Pulmonary hypertension, Lynch syndrome, Neural tube defects, Proteasome-associated autoinflammatory syndrome, Cone-Rod dystrophy, Leptin deficiency, Osteoarthritis, Interstitial lung disease, Medulloblastoma, Retinoblastoma, Autoimmune lymphoproliferative syndrome, Asthma, Head and neck squamous cell carcinoma, Lung cancer susceptibility, Chronic lymphocytic leukemia, Multiple myeloma, Ulcerative colitis, Autism spectrum disorder, Tuberous sclerosis, Familial Mediterranean fever, Tatton-Brown-Rahman syndrome, Familial adenomatous polyposis | K14R, D71H, D80H, D86H, D182H, D201H, D216H, D260H, D262H, D270H, D285H, D296H, D302H, D329H, D344H | Bardoxolone, Bryostatin 1, AN-9, Trichostatin A, Oleandrin, Emricasan, Z-VAD, VX-166 | |
CASP9 | 2AR9,1JXQ,3V3K,3YGS,4RHW,5WVC,1NW9,3D9T,5JUY,5WVE | ABL1,APAF1,ARNT,BCL2L1,BIRC2,BIRC3, BIRC5,BIRC6,BIRC7,BIRC8,CASP3,CASP8, HECTD3,NLRP1,XIAP | Apoptosis, Synaptic loss, Erythropoiesis, Embryonic development & leukemia, Muscle differentiation | Cancer (Colorectal, Lung, Prostate, Breast, Hepatocellular, Pancreatic, Ovarian, Gastric, Esophageal, Endometrial, Brain), Familial Alzheimer disease, Amyotrophic lateral sclerosis, Acute myeloid leukemia, Crohn’s disease, Osteoporosis, Parkinson disease (late onset), Type 1 diabetes mellitus, Ataxia-telangiectasia, Ischemic stroke, Nonpapillary renal cell carcinoma, Neural tube defects, Cone-Rod dystrophy, Osteoarthritis, Medulloblastoma, Schizophrenia, Dilated cardiomyopathy, Head and neck squamous cell carcinoma, Lung cancer susceptibility, Multiple myeloma, Autism spectrum disorder, Chronic lymphocytic leukemia, Ulcerative colitis, Tuberous sclerosis, Tatton-Brown-Rahman syndrome | L23V, A28V, L106V, T216N, T283N, T366N | Pamidronic acid, Emricasan, Z-VAD, VX-166 | |
CASP10 | – | CASP8,CFLAR,FADD,FAS,PRDX6,RIOK3, RNF34,TNFRSF10B,TNFRSF1A,XIAP | - | Cancer (Gastric, Colorectal, Lung, Prostate, Breast, Pancreatic, Ovarian, Brain, Esophageal), Systemic lupus erythematosus, Amyotrophic lateral sclerosis, Crohn’s disease, Rheumatoid arthritis, Pfeiffer syndrome, Lynch syndrome, Immune deficiency disease, Dilated cardiomyopathy, Retinoblastoma, Medulloblastoma, Autoimmune lymphoproliferative syndrome, Chronic lymphocytic leukemia, Asthma, Multiple myeloma, Familial adenomatous polyposis, Ulcerative colitis | K17E, V343I, A347V, V367I, A371V, Y379C, Y403C, V410I, A414V, Y446C, L455I, L479I, L522I | Emricasan, Z-VAD, VX-166 | |
CASP12 | – | MAGEA3 | ER stress | Cancer (Colorectal, Breast, Ovarian, Gastric), Type 2 diabetes mellitus, Malaria, Cardiovascular disease, Tuberous sclerosis | S53Nlb | Emricasan, Z-VAD, VX-166 | |
CASP14 | – | ALDH3A1,CCNF,FCF1,FTH1,MEOX2, MYC,TBC1D22B,TP53,ZIC1,ZRANB1 | Keratinocyte differentiation | Cancer (Prostate, Breast, Pancreatic, Gastric, Brain), Ischemic stroke, Head and neck squamous cell carcinoma, Autism spectrum disorder | L65V R179Qlb | Emricasan, Z-VAD, VX-166 |